StonvexLoading…
StonvexStonvexStonvexCore line items from AMAL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-07-27 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $93.93M | $109.31M | $422.23M | $314.38M | $204.79M |
Operating Income | Not available | $34.07M | $140.16M | $106.89M | $70.20M |
Net Income | Not available | $25.22M | $104.45M | $77.81M | $51.02M |
EPS (Diluted) | $1.01 | $0.84 | $3.41 | $2.53 | $1.65 |
Total Assets | Not available | $9.17B | $8.87B | $8.68B | $8.62B |
Total Liabilities | Not available | $8.36B | $8.08B | $7.91B | $7.87B |
Cash & Equivalents | Not available | $179.73M | $291.22M | $115.54M | $171.07M |
Free Cash Flow OCF − CapEx | Not available | $50.70M | $134.40M | $96.40M | $58.10M |
Shares Outstanding | Not available | 29.86M | 29.82M | 30.09M | 30.41M |